NUTRA PHARMA CORP.: 10-Q filed 2025-10-28

Name: NUTRA PHARMA CORP.: 10-Q filed 2025-10-28
Creator: NUTRA PHARMA CORP.

What NUTRA PHARMA CORP. reported in its quarterly report filed 2025-10-28 (fiscal Q3 2023): 44 published measures, 117 facts as tagged in accession 0001493152-25-019875.

This filing

Form: 10-Q (quarterly report)
Filed: 2025-10-28
Fiscal period: fiscal Q3 2023
Accession: 0001493152-25-019875 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NUTRA PHARMA CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2023-09-30	711,338	USD
At 2022-12-31	754,913	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2023-09-30	14,236,582	USD
At 2022-12-31	13,132,365	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2023-09-30	-13,525,244	USD
At 2023-06-30	-13,249,258	USD
At 2022-12-31	-12,377,452	USD
At 2022-09-30	-15,609,507	USD
At 2022-06-30	-16,197,236	USD
At 2021-12-31	-20,877,650	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2023-09-30	0	USD
At 2022-12-31	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-278,486	USD	92
2023-01-01 to 2023-09-30	-1,150,292	USD	273
2022-07-01 to 2022-09-30	577,229	USD	92
2022-01-01 to 2022-09-30	4,944,891	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	-363,807	USD	273
2022-01-01 to 2022-09-30	-708,400	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	57,993	USD	273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	51,612	USD	92
2023-01-01 to 2023-09-30	158,532	USD	273
2022-07-01 to 2022-09-30	24,624	USD	92
2022-01-01 to 2022-09-30	66,814	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	330,101	USD	273
2022-01-01 to 2022-09-30	641,684	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	33,706	USD	273
2022-01-01 to 2022-09-30	-24,194	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2023-09-30	-74,702,410	USD
At 2022-12-31	-73,552,118	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	7,613,406,562	shares	92
2023-01-01 to 2023-09-30	7,602,596,719	shares	273
2022-07-01 to 2022-09-30	7,592,286,997	shares	92
2022-01-01 to 2022-09-30	7,471,152,031	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	7,613,406,562	shares	92
2023-01-01 to 2023-09-30	7,602,596,719	shares	273
2022-07-01 to 2022-09-30	15,597,613,916	shares	92
2022-01-01 to 2022-09-30	15,104,777,470	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Unit	Days
2023-07-01 to 2023-09-30	USD/shares	92
2023-01-01 to 2023-09-30	USD/shares	273
2022-07-01 to 2022-09-30	USD/shares	92
2022-01-01 to 2022-09-30	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Unit	Days
2023-07-01 to 2023-09-30	USD/shares	92
2023-01-01 to 2023-09-30	USD/shares	273
2022-07-01 to 2022-09-30	USD/shares	92
2022-01-01 to 2022-09-30	USD/shares	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2023-09-30	63,684	USD
At 2022-12-31	80,012	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	20,500	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-165,767	USD	92
2023-01-01 to 2023-09-30	-746,757	USD	273
2022-07-01 to 2022-09-30	-236,521	USD	92
2022-01-01 to 2022-09-30	-886,031	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2023-09-30	363,839	USD
At 2022-12-31	333,577	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	4,808	USD	92
2023-01-01 to 2023-09-30	13,862	USD	273
2022-07-01 to 2022-09-30	4,272	USD	92
2022-01-01 to 2022-09-30	12,740	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2023-09-30	13,950,631	USD
At 2022-12-31	12,700,821	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2023-09-30	752,477	USD
At 2022-12-31	727,367	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2023-09-30	21,969	USD
At 2022-12-31	21,664	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	280,749	USD	92
2023-01-01 to 2023-09-30	1,049,473	USD	273
2022-07-01 to 2022-09-30	304,674	USD	92
2022-01-01 to 2022-09-30	991,557	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2023-09-30	29,087	USD
At 2022-12-31	23,866	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	114,982	USD	92
2023-01-01 to 2023-09-30	302,716	USD	273
2022-07-01 to 2022-09-30	68,153	USD	92
2022-01-01 to 2022-09-30	105,526	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	280,749	USD	92
2023-01-01 to 2023-09-30	944,008	USD	273
2022-07-01 to 2022-09-30	326,473	USD	92
2022-01-01 to 2022-09-30	991,557	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2023-09-30	7,064,727,214	shares
At 2022-12-31	7,039,727,214	shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2023-09-30	194,442	USD
At 2022-12-31	251,951	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2023-09-30	196,386	USD
At 2022-12-31	251,951	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2023-09-30	8,382,025	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2023-09-30	129,650	USD
At 2022-12-31	324,879	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2023-09-30	65,966	USD
At 2022-12-31	244,867	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2023-09-30	1,824,312	USD
At 2022-12-31	1,678,027	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2023-09-30	74,999	USD
At 2022-12-31	62,651	USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

Period	Value	Unit	Days
At 2023-09-30	360,149	USD
At 2022-12-31	181,515	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-278,486	USD	92
2023-01-01 to 2023-09-30	-1,150,292	USD	273
2022-07-01 to 2022-09-30	577,229	USD	92
2022-01-01 to 2022-09-30	4,944,891	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	5,442	USD	92
2023-01-01 to 2023-09-30	16,328	USD	273
2022-07-01 to 2022-09-30	5,898	USD	92
2022-01-01 to 2022-09-30	17,088	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-112,719	USD	92
2023-01-01 to 2023-09-30	-403,535	USD	273
2022-07-01 to 2022-09-30	813,750	USD	92
2022-01-01 to 2022-09-30	5,830,922	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	75,555	USD	273
2022-01-01 to 2022-09-30	84,460	USD	273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	73,494	USD	273
2022-01-01 to 2022-12-31	88,728	USD	365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	305	USD	273
2022-01-01 to 2022-09-30	-24,418	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	5,221	USD	273
2022-01-01 to 2022-09-30	9,557	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	25,111	USD	273
2022-01-01 to 2022-09-30	40,385	USD	273

Inspect the source

Entity: NUTRA PHARMA CORP. / CIK 0001119643
Captured: 2026-09-20T05:24:45.365Z
SEC response SHA-256: a9ccf17d1b07544de23a6dd72641e83d2b0b8f34b5c47b58fd5a236f1c887339

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001119643.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))